Last reviewed · How we verify
Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV
A Phase Ib trial to evaluate the safety and immunogenicity of R21/Matrix-M™ in African children living with HIV
Details
| Lead sponsor | University of Oxford |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 122 |
| Start date | Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Malaria
Interventions
- R21/Matrix-M™
Countries
Uganda